Cargando…
Dementia risk in the general population: large-scale external validation of prediction models in the AGES-Reykjavik study
We aimed to evaluate the external performance of prediction models for all-cause dementia or AD in the general population, which can aid selection of high-risk individuals for clinical trials and prevention. We identified 17 out of 36 eligible published prognostic models for external validation in t...
Autores principales: | Vonk, Jet M. J., Greving, Jacoba P., Gudnason, Vilmundur, Launer, Lenore J., Geerlings, Mirjam I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542560/ https://www.ncbi.nlm.nih.gov/pubmed/34308533 http://dx.doi.org/10.1007/s10654-021-00785-x |
Ejemplares similares
-
Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study
por: Olafsdottir, Elin, et al.
Publicado: (2011) -
Dementia prediction in the general population using clinically accessible variables: a proof-of-concept study using machine learning. The AGES-Reykjavik study
por: Twait, Emma L., et al.
Publicado: (2023) -
Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study
por: Sturlaugsdottir, Ran, et al.
Publicado: (2016) -
Fat Distribution and Mortality: The AGES-Reykjavik Study
por: Koster, Annemarie, et al.
Publicado: (2015) -
Similar decline in mortality rate of older persons with and without type 2 diabetes between 1993 and 2004 the Icelandic population-based Reykjavik and AGES-Reykjavik cohort studies
por: Olafsdottir, Elin, et al.
Publicado: (2013)